This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) as a Delivery Order under an Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 through December 31, 2025. The contract provides for the supply of a wide range of pharmaceutical products and medical supplies, including specialty, brand name, generic, and over-the-counter medications, as well as critical care materials such as syringes, vials, and test kits, to support Department of Defense facilities and operations worldwide. This is a firm fixed-price contract with no set-aside designation, highlighting Amerisourcebergen's competitive position in the federal pharmaceutical supply market. The current Delivery Order has a ceiling value of $14,715.77 and covers the provision of 36,000 unit capsules of the drug "CREON DR" for delivery by July 9, 2024.
Generated 10/7/24, 10:56 AM